Publications. A. Thesis/ Habilitation. B. Full papers/ Letters/ Case reports:

Transkript

1 Publications A. Thesis/ Habilitation Went P. Went P. Die Plattenepithelnester der Pars tuberalis der Hypophyse: eine immunhistochemische Untersuchung Medizinische Fakultät der Universität Basel, Basel, Schweiz 1996 Prognostische und prädiktive Faktoren bei ausgewählten malignen Tumoren Fach: Allgemeine und spezielle Pathologie Medizinische Fakultät der Universität Basel, Basel, Schweiz 2007 Mentor: 1. Mayer, Serge Quantifizierung von Plasmazellen im Knochenmark mittels computergesteuerter Bildanalyse Medizinische Fakultät der Universität Basel, Basel, Schweiz Dellas, Theresa Expression profile of p53/p21, MUM-1 and CD44v6 in over 600 cases of Non-Hodgkin lymphoma: a tissue microarray study with clinicopathological analysis of diffuse large B-cell lymphomas Medizinische Fakultät der Universität Basel, Basel, Schweiz 2006 Preis der Mary & Ewald E. Bertschmann Stiftung für die beste med. Dissertation 2005/06 der med. Fakultät BS 3. Roten, Lukas Proteinexpression in Schilddrüsenneoplasien: Eine Gewebearray-Untersuchung (Teil A) Medizinische Fakultät der Universität Basel, Basel, Schweiz Rothe, Thilo Proteinexpression in Schilddrüsenneoplasien: Eine Gewebearray-Untersuchung (Teil B) Medizinische Fakultät der Universität Basel, Basel, Schweiz Münst, Simone Klinische und immunphänotypische Charakterisierung von peripheren T-Zell-Lymphomen Medizinische Fakultät der Universität Basel, Basel, Schweiz d Hondt, Steven Primäre Knochenlymphome klinische und histologische Charakterisierung Medizinische Fakultät der Universität Basel, Basel, Schweiz 2009 B. Full papers/ Letters/ Case reports: 1. Pileri SA, Sabattini, E, Ascani S, Bacci F, Went P. Indolent lymphoma: the pathologist viewpoint Haematologica, 2003; 88, Suppl.10:112-13, IF (2006) 4.192, Ranking 12/62 (Hematology) 2. Went P, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S. Frequent EpCam-Protein-Expression in human carcinomas Hum Pathol, 35:122:128, 2004, IF (2006) 3.369, Ranking 10/65 (Pathology) 3. Went P, Ascani S, Sabattini E, Heyerdahl Strøm E, Brorson S-H, Musso M, Zinzani P, Falini B, Dirnhofer S, Pileri S. Nodal marginal zone lymphoma associated with light and heavy chain deposition disease Lancet Oncology, 5:381-83, 2004, IF (2006) 7.470, Ranking 10/123 (Oncology), Case Report 4. Went P, Dirnhofer S, Bundi M, Mirlacher M, Schraml P, Mangialaio S, Dimitrijevic S, Kononen J, Lugli A, Simon R, Sauter G. Prevalence of KIT expression in human tumors

2 J Clin Oncol, 22(22): , 2004, IF (2006) 9.835, Ranking 6/123 (Oncology) 5. Went P, Dellas T, Bourgau C, Maurer R, Augustin F, Tzankov A, Dirnhofer S. Expressionsmuster und prognostische Bedeutung von CD24, p53 und p21 in Lymphomen. Eine Gewebe- Mikroarray-Studie an über 600 Non-Hodgkin-Lymphomen Dtsch Med Wochenschr, 129: , 2004, IF (2006) 0.552, Ranking 72/103 (General and Internal Medicine) 6. Went P, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch H. Expression of Epithelial Cell Adhesion Molecule (EpCam)in Renal Epithelial Tumors Am J Surg Pathol, 29(1):83-88, 2005, IF (2006) 4.690, Ranking 4/65 (Pathology) 7. Went P, Zimpfer A, Pehrs AC, Pileri S, Maurer R, Terracciano L, Tzankov A, Dirnhofer S. High Specificity of Combined TRAP and DBA.44 Expression for Hairy Cell Leukemia Am J Surg Pathol, 29(4):474-78, 2005, IF (2006) 4.690, Ranking 4/65 (Pathology) 8. Bucher C, Degen L, Dirnhofer S, Pless M, Hermann R, Schraml P, Went P. Rectal anaplastic large T-cell lymphoma followed by diffuse large B-cell lymphoma in a patient with longstanding Crohn s disease Gut, 54:732-33, 2005, IF (2006) Ranking 3/46 (Gastroenterology and Hepatology), Case Report 9. Went P, Dirnhofer S, Stallmach T, Taverna C, Singer G. Placental site trophoblastic tumor of the mediastinum Hum Pathol, 36:581-84, 2005, IF (2006) 3.369, Ranking 10/65 (Pathology), Case Report 10. Went P, Dirnhofer S. Fortschritt durch Differenzierung Ärztemagazin Universitätsspital Basel Frühjahr:13, 2005, not listed, not peer-reviewed, not ranked 11. Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede, U, Kononen J, Simon R, Sauter G, Baeuerle PA. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers Brit J Cancer, 94: , 2006, IF (2006) 3.742, Ranking 33/123 (Oncology) 12. Mayer S, Dirnhofer S, Oberholzer M, Went P. Quantification of bone marrow plasma cells by computer-assisted image analysis Histology and Histopathology, 21: , 2006, IF (2006) 1.931, Ranking 21/65 (Pathology) 13. Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T, Paulli M, Artusi T, Alinari L, Zinzani PL, and Pileri SA on behalf of the Intergruppo Italiano Linfomi (ILL) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score J Clin Oncol, 24(16):1-8, 2006, IF (2006) 9.835, Ranking 6/123 (Oncology) 14. Dirnhofer S, Zimpfer A, Went P. Die prognostische und prädiktive Bedeutung von KIT (CD117) Ther Umsch, 63(4): , 2006, listed, peer-reviewed, not ranked Histo Journal, 26(1):6-11, 2007, not listed, not peer-reviewed, not ranked 15. Tzankov A, Gschwendtner A, Augustin F, Fiegl M, Obermann EC, Dirnhofer S, Went P. Inferior Outcome Diffuse Large B-Cell Lymphoma with Overexpression of Cyclin E Substantiates Poor Standard Treatment Response and Inferior Outcome Clin Cancer Res, 12(7): , 2006, IF (2006) 5.623, Ranking 14/123 (Oncology) 16. Went P, Sauter G, Oberholzer M, Bubendorf L. Abundant expression of AMACR in many distinct tumor types

3 Pathology, 38(5):426-32, 2006, IF (2006) 1.260, Ranking 39/65 (Pathology) 17. Went P, Schwaller J, Tzankov A, Passweg J, Roosnek E, Huard B. Role of the TNF ligand APRIL in Hodgkin s lymphoma: a retrospective study including 107 cases Exp Hematol, 36:533-34, 2008, Letter 18. Adams H, Tzankov A, d Hondt S, Jundt G, Dirnhofer S, Went P. Primary diffuse large B-cell lymphomas of the bone: Prognostic relevance of protein expression and clinical factors Hum Pathol, 39(9): , 2008, IF (2006) 3.369, Ranking 10/65 (Pathology) 19. Went P, Dirnhofer S, Schöpf D, Moch H, Spizzo G. Expression and prognostic significance of EpCAM (CD326) JOCM, 3(6):169-74, 2008, not listed, peer-reviewed, not ranked 20. Went P, Seemayer CA, Pileri S, Maurer R, Tzankov A, Dirnhofer S. Lack Of Protein Expression Of The Simian Virus 40 Large T Antigen In Human Lymphomas J Med Virol, 80:1112:1115, Decker M, Went P. Placental barrier function in acute myeloid leukämie Br J Haematol, 2008 November [Epub ahead of print], doi: /j x, Went P, Zimpfer A, Tzankov A, Dirnhofer S. CD5 expression in de novo diffuse large B cell lymphomas Ann Oncol, January 2009 [Epub ahead of print], doi: /annonc/mdn793, 2009, Letter Coauthor: 23. Graf R, Schiesser M, Lussi A, Went P, Scheele GA, Bimmler D. Coordinate regulation of secretory stress proteins (PSP/reg, PAP I, PAP II, and PAP III) in the rat exocrine pancreas during experimental acute pancreatitis J Surg Res (2):136-44, IF (2006) 1.727, Ranking 36/139 (Surgery) 24. Pileri SA, Dirnhofer S, Went P, Ascani S, Sabattini E, Marafioti T, Tzankov A, Leoncini L, Falini B, Zinzani P L. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification Histopathology (6): , IF (2006) 2.955, Ranking 12/65 (Pathology), Review 25. Birchler MT, Landau K, Went P, Stoeckli JS. Paraganglioma of the Cervical Sympathetic Trunk Ann Otol Rhinol Laryngol (12): , IF (2006) 1.077, Ranking 11/29 (Otorhinolaryngology), Case Report 26. Tzankov A, Zimpfer A, Lugli A, Krugmann J, Went P, Schraml P, Maurer R, Ascani S, Pileri SA, Geley S, Dirnhofer S. High-throughput tissue microarray analysis of G 1 -Cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1 J Pathol 2003; 199(2): , IF (2006) 5.333, Ranking 2/65 (Pathology) 27. Spizzo G, Obrist P, Went P, Dirnhofer S, Gastl G. Edrecolomab in the adjuvant treatment of colorectal carcinoma Lancet 2003; 361(9351):83, IF (2006) , Ranking 3/103 (Internal and General Medicine), Letter

4 28. Singer G, Schraml P, Belgard C, Raggi A, Dirnhofer S, Went P, Mihatsch MJ, Moch H. KIT in ovarian carcinoma: Disillusion about a potential therapeutic target J Natl Cancer Inst, 95 (13), 2003, IF (2006) , Ranking 5/123 (Oncology), Letter 29. Theurillat J-P, Vavricka SR, Went P, Weishaupt D, Perren A, Leonhard-Meier C, Bächli EB. Morphologic changes and altered gene expression in an epithelioid Hemangioendothelioma during a tenyear course of disease Pathol Res Pract, 199 (3):165-70, 2003, IF (2006) 0.681, Ranking 54/65 (Pathology) 30. Tzankov A, Zimpfer A, Pehrs AC, Lugli A, Went P, Maurer R, Pileri SA, Dirnhofer S. Expression of B-cell markers in classical Hodgkin Lymphoma: a tissue microarray analysis of 330 cases Mod Pathol, 16(11): , 2003, IF (2006) 3.643, Ranking 7/65 (Pathology) 31. Brauchli K, Banach L, Dalque P, Haroske G, Hurwitz N, Kunze KD, Jundt G, Oberli H, Stauch G, Went P, Oberholzer M. Telemedizin weltweit mit einem offenen und verteilten Telemedizinsystem Schweizerische Aerztezeitung, 84 (32-33): , 2003, not listed, not peer-reviewed, not ranked 32. Ascani S, Went P, Liberati AM, Piccaluga PP, Zinzani PL, Pileri SA. True thymic hyperplasia J Clin Oncol, 22 (5):953-54, 2004, IF (2006) 9.835, Ranking 6/123 (Oncology), Case Report 33. Pileri SA, Zinzani PL, Went P, Pileri A Jr, Bendandi M. Indolent lymphoma: the pathologist s viewpoint Ann Oncol, 15:12-18, 2004, IF (2006) 4.335, Ranking 25/123 (Oncology), Review 34. Lugli A, Went P, Khanlari B, Nikolova Z, Dirnhofer S. Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment Virchows Arch, 444:264-68, 2004, IF (2006) 2.357, Ranking 18/65 (Pathology) 35. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, Von Castelberg B, Bart R, Stopatschinskaya S, Kochli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer Breast Cancer Res Treat, 86(3):207-13, 2004, IF (2006) 3.310, Ranking 39/123 (Oncology) 36. Zimpfer A, Went P, Tzankov A, Pehrs AC, Lugli A, Maurer R, Terracciano L, Pileri S, Dirnhofer S. Rare Expression of KIT (CD117) in lymphomas: A Tissue Microarray Study of 1166 cases Histopathology, 45: , 2004, IF (2006) 2.955, Ranking 12/65 (Pathology) 37. Tzankov A., Zimpfer A, Went P, Maurer R, Pileri S, Geley S, Dirnhofer S. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma Mod Pathol, 18:90-96, 2005, IF (2006) 3.643, Ranking 7/65 (Pathology) 38. Obermann EC, Went P, Pehrs AC, Alexander Tzankov A, Wild PJ, Pileri S, Hofstaedter F, Dirnhofer S. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma Oncol Rep, 14(6):1461-7, 2005, IF (2006) 1.572, Ranking 93/123 (Oncology) 39. Tzankov A, Went P, Zimpfer A, Dirnhofer S. Tissue microarray technology: principles, pitfalls and perspectives lessons learned from hematological malignancies Exp Gerontol, 40(8-9):737-44, 2005, IF (2006) 3.008, Ranking 12/29 (Geriatrics & Gerontology), Evaluation Study

5 40. Obermann EC, Went P, Zimpfer A, Tzankov A, Wild PJ, Stoehr R, Pileri SA, Dirnhofer S. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis BMC Cancer, 5:162, 2005, IF (2006) 2.290, Ranking 60/123 (Oncology) 41. Lawrie CH, Marafioti T, Hatton CSR, Dirnhofer S, Roncador G, Went P, Tzankov A, Pileri SA, Pulford K, Banham AH. Cancer-associated carbohydrate identification in Hodgkin s lymphoma by carbohydrate array profiling Int J Cancer, 118(12):3161-6, 2006, IF (2006) 4.416, Ranking 23/123 (Oncology) 42. Rimner T, Went P, Tichelli A, Gratwohl A. Concomitant hairy cell and acute myeloid leukemia Eur J Hematol, 76:86-88, 2006, IF (2006) 1.729, Ranking 34/62 (Hematology), Case Report 43. Adams H, Went P, Tolnay M, Sartorius G, Singer G. Meningotheliomatöses Meningeom in einem reifen zystischen Teratom des Ovars Pathologe, 28(4): , 2007, IF (2006) 0.492, Ranking 59/65 (Pathology), Case Report 44. Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG. Overexpression of Epithelial Cell Adhesion Molecule (Ep-CAM) is an Independent Prognostic Marker for Reduced Survival of Patients with Epithelial Ovarian Cancer Gyn Oncol, 103(2):483-8, 2006, IF (2006) 2.083, Ranking 67/123 (Oncology) 45. Zimpfer A, Schönberg S, Lugli A, Agostinelli C, Pileri SA, Went P, Dirnhofer S. Construction and validation of a bone marrow tissue microarray J Clin Pathol, 60(1):57-61, 2007, IF (2006) 2.619, Ranking 15/65 (Pathology) 46. Obermann EC, Went P, Tzankov A, Pileri SA, Hofstädter F, Marienhagen J, Stoehr R, Dirnhofer S. Cell cycle phase distribution analysis in chronic lymphocytic leukemia: a significant number of cells reside in early G1-phase J Clin Pathol, 60(7):794-7, 2006, IF (2006) 2.619, Ranking 15/65 (Pathology) 47. Zimpfer A, Schonberg S, Lugli A, Agostinelli C, Pileri SA, Went P, Dirnhofer S. Construction and validation of a bone marrow tissue micro array J Clin Pathol, 60:57-61, Tzankov A, Went P, Munst S, Papadopoulos T, Jundt G, Dirnhofer S. Rare expression of BSAP (PAX-5) in mature T-cell lymphomas Mod Pathol, 20:632-37, Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S, Went P, Klein U, Zinzani, PL, Baccarani M, Dalla Favera R, Pileri, SA. Gene expression analysis of peripheral T-cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets J Clin Invest, 117(3):823-34, Schwaller J, Went P, Matthes T, Dirnhofer S, Donze O, Mhawech-Fauceglia P, Myit S, Huard B. Paracrine promotionof tumor development by the TNF ligand APRIL in Hodgkin s Disease Leukemia, 21(6):1324-7, 2007, Letter 51. Dirnhofer S, Went P, Tichelli A. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS Pathobiology, 74:115-20, 2007, Review

6 52. Winkler DT, Strnad P, Meier ML, Roten S, Went P, Steck AJ, Lyrer P. Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade J Neurol, 254(11):1601-3, 2007, Case report 53. Pleyer L, Went P, Russ G, Prinz E, Faber V, Rowert HJ, Karlbauer R, Greil R. Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C Wien Klin Wochenschr, 119(7-8): , 2007, Case report 54. Tzankov A, Went P, Dirnhofer S. Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas Biomarker Insights, 2: , 2007, Review 55. Holbro A, Dirnhofer S, Went P, Tyndall A, Daikeler T. Bone marrow histology in a patient with fever of unknown origin J Rheumatol, 35(2): , 2008, Case report 56. Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S. Correlation of high numbers of intratumoral FOXP3 regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma,follicular lymphoma and classical Hodgkin s lymphoma Haematologica, 93(2): , 2008, IF (2007) 5.32, Ranking 3/62 (Hematology) 57. Franzen D, Went P, Buehlmann U. Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis Indian J Gastroenterol, 27(3): , 2008, Letter 58. Tzankov A, Sotlar K, Muhlematter D, Theocharides A, Went P, Jotterand M, Horny HP, Dirnhofer S. Systemic mastocytosis with associated myeloproliferative disease and precursor B-lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3 J Clin Pathol, 61(8):958-61, Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, Ziegler D, Kren A, Went P, Derksen PWB, Berns A, Jonkers J, Christofori G. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin EMBO J, 27(19): , Agostinelli C, Piccaluga PP, Went P, Rossi M, Gazzola A, Righi S, Sista MT, Campidelli C, Zinzani PL, Falini B, Pileri SA. Peripheral T-cell lymphoma not otherwise-specified: the stuff of genes, dreamsand therapies J Clin Pathol, 61(11): , Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, Gires O. Nuclear Signalling by tumour-associated Antigen EpCAM Nature Cell Biology, published online 11 January 2009; DOI /ncb1824, Meier C, Hoeller S, Bourgau C, Hirschmann P, Schwaller J, Went P, Pileri S, Reiter A, Dirnhofer S, Tzankov A. Recurrent numeric aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas Modern Pathology, 22(1):1-12, Zingg U, Montani M, Busch M, Metzger U, Went P, Oertli D. Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pn0 oesophageal cancer Eur J Surg Oncol Jan 2. [Epub ahead of print], 2009

7 C. Books/ -sections 1. Dirnhofer S, Went P. Histologische Klassifikation und Diagnose in: Lymphoproliferative Erkrankungen, Greil R (Hrsg.), UNI-MED Science, Bremen, 1. Auflage, ISBN , 17-28, 2007 D. Abstracts: 1. P. Went, T. Zellweger, U. Wagner, K. Suess, F. Bannwart, G. Sauter, U. Schmid, W. Wegmann, T. Hardmeier, M. Anabitarte, M. Mihatsch, R. Maurer Prognostische Bedeutung der Infiltrationstiefe von pt1 Urothelcarcinomen Jahrestagung der Schweiz. Gesellschaft für Pathologie Bern/CH, , Schweiz Med Wochenschr, 127 (42), A26, P. Went, HP. Honegger, F. Bannwart, R. Maurer Die Differentialdiagnose des small blue round cell tumours bei der Frau. Jahrestagung der Schweiz. Gesellschaft für Pathologie Zürich/CH, Schweiz Med Wochenschr, 130 (40), A12, P. Went, A. Lugli, S. Meier, M. Bundi, M. Mirlacher, G. Sauter, S. Dirnhofer Analysis of EpCam Protein Expression in 134 different human tumor types 87. Tagung der deutschen Gesellschaft für Pathologie, , Bamberg/D, Pathol Res Pract, Vol.199, Suppl.4, 2003, P232, P. Went, A. Zimpfer, AC. Pehrs, A. Tzankov, S. Pileri, S. Mayer, S. Dirnhofer Combined immunohistochemical positivity for TRAP and the antibody DBA.44 is infrequent in NHL other than HCL Jahrestagung der deutschen, österreichischen und schweizerischen Gesellschaft für Onkologie, , Basel/CH, Onkologie, 26 (S5), P849, P. Went, S. Dirnhofer, T. Salvisberg, M.B. Amin, S.D. Lim, P.-A. Diener, H. Moch EpCam adhesion molecule in adult renal neoplasms: Potential utility in the differential diagnosis of chromophobe renal cell carcinoma and oncocytoma Jahrestagung der US-amerikanischen und kanadischen Pathologen, , Vancouver/Canada, Hum Pathol 17(Suppl 1):276A, P. Went, A. Zimpfer, AC. Pehrs, A. Tzankov, S. Pileri, S. Mayer, S. Dirnhofer, Combined Immunohistochemical Positivity For Tartrate-Resistant Acid Phosphatase And The Antibody DBA.44 Is Infrequent In Non-Hodgkin-Lymphoma Other Than Hairy Cell Leukemia Jahrestagung der USamerikanischen und kanadischen Pathologen, , Vancouver/Canada, Hum Pathol 17(Suppl 1):184A, P. Went, S. Mayer, F. Gudat, S. Dirnhofer, Quantification of CD138 labelled plasma cells: Comparison of conventional and semiautomatic image analysis 88. Jahrestagung der Deutsch. Gesellschaft für Pathologie, , Rostock/D, Path Res Pract 200 (4), A129, P. Went, A. Zimpfer, AC. Pehrs, S. Mayer, S. Pileri, R. Maurer, A. Tzankov, S. Dirnhofer. Rare combined positivity for Tartrate-resistant Phosphatase and DBA.44 in NHL other than HCL 88. Jahrestagung der Deutsch. Gesellschaft für Pathologie, , Rostock/D, Path Res Pract 200 (4), A338, P. Went, C. A. Seemayer, S. Pileri, R. Maurer, A. Tzankov, S. Dirnhofer Lack Of Large T-Antigen Of SV40 In Lymphomas First International Symposium on Infection-Driven Lymphomas in Roma/It, , P 10. P. Went, C. A. Seemayer, S. Pileri, R. Maurer, A. Tzankov, S. Dirnhofer Lack Of Large T-Antigen Of SV40 In Lymphomas 9 th International Congress on Malignant Lymphomas, Lugano/CH, P, , Ann Oncol 16:5S

8 11. S. d Hondt, G.Jundt, S. Dirnhofer, P. Went Primäre Knochenlymphome- Klinische und histologische Charakterisierung 71. Jahrestagung der Schweiz. Gesellschaft für Pathologie, , Basel/CH, Pathologe 27 (2), 162, T. Dellas, S. Dirnhofer, A. Tzankov, R. Maurer, P. Went, Prognostische Bedeutung von CD44v6 und MUM- 1 Expression in diffus grosszelligen B-Zell Lymphomen 71. Jahrestagung der Schweiz. Gesellschaft für Pathologie, , Basel/CH, Pathologe 27 (2), 160, P. Went EpCam in Human Malignancies:Distribution and Frequency Detected by Immunohistochemistry Vortrag, 1st International Symposion on EpCAM Function and Clinical Application, München/D, , O 14. A. Tzankov, A. Gschwendtner, F. Augustin, M. Fiegl, E.C. Obermann, S. Dirnhofer, P. Went Cyclin E (CCNE)-Überexpression in diffus großzelligen B-Zelllymphomen (DLBCL) als negativer prognostischer Faktor 71. Jahrestagung der Schweiz. Gesellschaft für Pathologie, , Basel/CH, Pathologe 27 (2), 160, P. Went, C. Agostinelli, A. Gallamini, PP. Piccaluga, S. Ascani, E. Sabattini, F. Bacci, B. Falini, T. Motta, M. Paulli, T. Artusi, P. Zinzani, S. Pileri Marker Expression in peripheren T-Zell-Lymphomen: Vorschlag eines prognostischen Scores 90. Jahrestagung der Deutschen Gesellschaft für Pathologie, Berlin/D, , Path Res Pract, 202 (4), A250, 2006, O 16. P. Went, L. Tornillo, H. Yurtsever, J. Briner, S. Dirnhofer GIST oder Fibromatose 72. Jahrestagung der SGPath, Bern/CH, , A3, O, Pathologe 28 (1), 74, S. Münst, S. Dirnhofer, Ch. Ruiz, P. Went Klinische und immunphänotypische Charakterisierung von peripheren T-Zell-Lymphomen 72. Jahrestagung der SGPath, Bern/CH, , A38, P, Pathologe 28 (1), 81, H. Adams, S. d Hondt, G. Jundt, S. Dirnhofer, A. Tzankov, P. Went MUM1 Expression als Marker einer geringeren Überlebenswahrscheinlichkeit von Patienten mit primärem, diffusem, grosszelligem B-Zell- Lymphom des Knochens Jahrestagung der deutschen, österreichischen und schweizerischen Gesellschaft für Onkologie, , Basel/CH, Onkologie, 30 (S3), P587, 2007 Coauthor: 19. F. Gudat, I. Levkowitz, P. Went, R. Albrecht, G. Feichter, M. Oberholzer, M.J. Mihatsch. DNA flowcytometry of colorectal adenomas Third Conference of the European Society for Analytical Cellular Pathology, , Grenoble/France, Anal Cell Pathol, Vol. 6 (3) A325, T. Zellweger, P. Went, G. Sauter, H. Knonagel, G. Alund, TC. Gasser, DK. Ackermann Prognostic relevance of the depth of invasion in stage T1 bladder carcinoma J Urol 159 (5): 544 Suppl, Th. Scherer, K. Klingler, J. Barandun, E. Scheuer, P. Went, U. Metzger, R. Inderbitzi Detektion von prämalignen Läsionen des Bronchialepithels: Weisslicht vs Autofluoreszenz-Bronchoskopie Jahrestagung der Schweiz. Gesellschaft für Pneumologie, , Genf/CH, available at: Fehler! Hyperlink-Referenz ungültig. 22. K. Klingler, J. Barandun, P. Went, E. Scheuer, U. Metzger, R. Inderbitzi Preneoplastic endobronchial lesions in a healthy, asymptomatic high-risk population - 14 month follow-up Jahrestagung der Schweiz. Gesellschaft für Pneumologie und der Schweiz. Gesellschaft für Thoraxchirurgie, , Bern/CH, available at: Fehler! Hyperlink-Referenz ungültig.

9 23. S. Dirnhofer, A. Tzankov, A. Zimpfer, A. Lugli, P. Went, J. Krugmann, R. Maurer, S Pileri Highthroughput tissue microarray analysis of cyclin E Gene amplification and expression of cyclin D1, D3 and E in 330 cases of classical Hodgkin Lymphoma XI Meeting of the European Bone Marrow Society, , Siena/Italy, J Clin Pathol 55 (SupplI): A34, A. Tzankov, A. Lugli, A. Zimpfer, P. Went, S. Pileri, S. Dirnhofer Tissue microarray analysis of CD44- expression in B-cell NHL XI Meeting of the European Bone Marrow Society, , Siena/Italy, J Clin Pathol 55 (SupplI): A29, S. Dirnhofer, P. Went, A. Lugli, A. Zimpfer, S.Mangiaiola, G. Sauter, J. Kononen Evaluation of CD117- immunohistochemistry using the tissue-microarray technology XXIVth International Congress of the International Academy of Pathology 2002, Amsterdam/Niederlande, , Histopathology, Vol.41:54, Suppl.1, A. Zimpfer, A. Tzankov, A. Lugli, P. Went, J. Krugmann, R. Maurer, S. Pileri, S. Dirnhofer Expression of cyclin A, D1, D3 and E1 in 330 cases of classical Hodgkin lymphoma: A high-throughput tissue microarray (TMA) study XXIVth International Congress of the International Academy of Pathology, , Amsterdam/Niederlande, Histopathology, Vol.41:14, Suppl.1, T. Scherer, K. Klingler, J. Barandun, P. Went, E. Scheuer, U. Metzger, R. Inderbitzi Preneoplastic endobronchial lesions in healthy high-risk subjects International conference of the American thoracic society Atlanta/USA, Poster C41, S. Dirnhofer, P. Went, S. Mangialaio, A. Zwimpfer, J. Kononen, G. Sauter Die immunhistochemische Analyse von KIT (CD117) zeigt niedrige Expressionsmuster in den häufigsten Karzinomen 31. Tagung der oberrhein. Pathologen, Heidelberg/D, E. Spizzo, G. Gastl, D. Wolf, E. Gunsilius, A. Amberger, R. Margreiter, P. Obrist, P. Went, G. Sauter, S. Dirnhofer, A. Tzankov High throughput tissue microarray analysis on the prognostic value of Ep-CAM overexpression, Frühjahresversammlung der österreich. Gesellschaft für Hämatologie und Onkologie, , Dornbin/AU, Acta Medica Austriaca 30:Suppl. 61, F. Augustin, A.-C. Pehrs, A. Zimpfer, P. Went, M. Fiegl, R. Greil, S. Dirnhofer, A. Tzankov Prognostic impact of clinical and immunohistochemical parameters in 113 cases of diffuse large B-cell lymphoma. A tissue microarray based single institutional study Frühjahresversammlung der österreich. Gesellschaft für Hämatologie und Onkologie, , Dornbirn/AU, Acta Medica Austriaca 30:Suppl. 61:16, F. Agustin, AC. Pehrs, A. Tzimpfer, P. Went, M. Fiegl, R. Greil, S. Dirnhofer, A. Tzankov Prognostic impact of clinical and immunohistochemical parameters in 113 cases of DLBCL- a TMA based study Jahrestagung der deutschen, österreichischen und schweizerischen Gesellschaft für Onkologie, , Basel/CH, Onkologie, 26 (S5), P888, A. Bucher, L. Degen, P. Went, S. Dirnhofer, M. Pless, C. Rochlitz, R. Herrmann Ki1+/ALK-anaplastic TCL in a Crohn s patient after Infliximab therapy Jahrestagung der deutschen, österreichischen und schweizerischen Gesellschaft für Onkologie, , Basel/CH, Onkologie, 26 (S5), P911, A. Tzankov, A. Zimpfer, AC. Pehrs, A. Lugli, P. Went, R. Maurer, S. Pileri, S. Dirnhofer Expression of B- cell markers in classical Hodgkin lymphoma: A tissue microarray analysis of 330 cases. 19th European Congress of Pathology, Ljubljana/Slovenien, , Virchows Archiv 443:274, A. Zimpfer, A. Tzankov, A.-C. Pehrs, A. Lugli, P. Went, R. Simon, R. Maurer, S. Pileri, S. Dirnhofer Expression of B-cell markers in 330 cases of classical Hodgkin Lymphoma: a tissue micro array study 87. Tagung der deutschen Gesellschaft für Pathologie, Bamberg/D, , Pathol Res Pract, 199 (4), P350, 2003

10 35. S. Dirnhofer, P. Went, A. Lugli, M. Bundi, S. Dimitrijevic, Z. Nikolova, M. Mihatsch, G. Sauter Potential tumor targets for Imatinib mesylate (Glivec ) therapy: High throughput tissue microarray analysis of c-kit expression 87. Tagung der deutschen Gesellschaft für Pathologie, Bamberg/D, , Pathol Res Pract, 199 (4), P151, M. Oberholzer, L. Banach, N. Hurwitz, G. Haroske, G. Jundt, K.D. Kunze, G. Stauch, P. Went, H. Oberli, K. Brauchli Telemedicine worldwide: Two years of experience in Telediagnostic 69. Jahrestagung der SGPath, , Warth/CH 37. A. Zimpfer, AC. Pehrs, A Tzankov, P. Went, R. Maurer, S. Pileri, S. Dirnhofer Frequency of CD5 expression and its association with trisomy 3and 7 in DLBCL: a TMA anaysis of 306 cases Jahrestagung der Deutsch. Gesellschaft für Pathologie, Rostock/D, , Path Res Pract 200 (4), Abstract 127, A. Zimpfer, S. Schönberg, A. Lugli, S. Pileri, P. Went, S. Dirnhofer, Tissue microarrays as a valuable tool in leukemia research XII meeting of the European bone marrow society, Thessaloniki/Greece, , J Clin Pathol (Suppl), A. Zimpfer, AC. Pehrs, A. Tzankov, R. Maurer, C. Maurischat, S. Pileri, P. Went, S.Dirnhofer, Negative correlation of CD5-positive de novo diffuse large B-cell lymphomas and trisomy 3 and 7. XII meeting of the European bone marrow society, Thessaloniki/Greece, , J Clin Pathol (Suppl), A. Zimpfer, C. Bourgau, A. Tzankov, S. Pileri, R. Maurer, M. Mirlacher, G. Sauter, P. Went, S. Dirnhofer T-cell marker expression in classical Hodgkin lymphoma Jahrestagung der Deutsch. Gesellschaft für Pathologie, Wuppertal/D, , Path Res Pract 201, 180, A. Gallamini, S. Tavera, S. Pileri, C. Agostinelli, P. Went, G. Todeschini, P.L. Zinzani, M. Liberati, G. Leonardi, M. Bellei, M. Federico Validation of PIT prognostic model on a new cohort of patients with a centrally reviewed diagnosis of peripheral T-cell lymphoma, unspecified (PTCL-U) Jahrestagung der Europ. Assoc. Hematology, , Stockholm/Sweden, P0262, available at: Abstract PIT 42. A. Tzankov, C. Bourgau, A. Zimpfer, A. Rufle, R. Maurer, S. Pileri, P. Went, S. Dirnhofer Rare expression of T-cell markers in classical Hodgkin lymphoma 9 th International Congress on Malignant Lymphoma, Lugano/CH, Poster, , Ann Oncol 16:5S 43. A. Zimpfer, C. Bourgau, A. Kaiser, S.A. Pileri, P. Went, A. Tzankov, S. Dirnhofer Expression of T-cell markers in classical Hodgkin Lymphoma is rare: A tissue microarray study 20 th Congress of the European Society of Pathology, Paris/France, , Virchows Archives, 447(2):253 P E. C. Obermann, P. Went, A. Pehrs, A. Tzankov, P. J. Wild, S. Pileri, F. Hofstaedter, S. Dirnhofer Cyclin B1 als neuer Prognostischer Marker bei diffus großzelligen B-Zell Lymphomen 71. Jahrestagung der SGPath, , Basel/CH, Pathologe 27 (2), 160, P.P. Piccaluga, P. Went, C. Agostinelli, A. Gallamini, S. Ascani, E. Sabattini, F. Bacci, B. Falini, T. Motta, M. Paulli, T. Artusi, P. L. Zinzani, M. Baccarani, S. A. Pileri, on Behalf of the Intergruppo Italiano Linfomi Marker Expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical- Pathologic Prognostic Score 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia/USA, , Blood, 106(11), O2819, P.P. Piccaluga, C. Agostinelli, S. Zupo, A. Califano, P. Went, S. Ascani, K. Basso, F. Facchetti, B. Falini, M. Ferrarini, A. Gallamini, U. Klein, D. Novero, M. Paulli, S. Tura, P. L. Zinzani, M. Baccarani, R. Dalla- Favera, S. A. Pileri Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia/USA, , Blood, 106(11), O1217, 2005

11 47. K. Aebi, E. Visca, S. Tercanli, P. Went, HP. Marti, E. Wight, W. Holzgreve Peritonitis mit Enterobius vermicularis nach Hysterektomie Jahresversammlung / Kongress der gynécologie suisse, Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe, Interlaken /CH, , P I A. Tzankov, A. Gschwendtner, F. Augustin, M. Fiegl, E.C. Obermann, P. Went, S. Dirnhofer Diffuse großzellige B-Zelllymphome mit Überexpression von Cyclin E sind mit schlechtem Ansprechen auf Standardtherapie und schlechtem Überleben assoziiert 90. Jahrestagung der Deutschen Gesellschaft für Pathologie, Berlin/D, , Path Res Pract, 202 (4), A248, 2006, O 49. A. Tzankov, C. Meier, P. Went, S. Dirnhofer Ein hoher Anteil FOXP3+ regulatorischer T-Zellen ist mit besseren allgemeinen Überlebensraten bei diffus grosszelligen B-Zelllymphomen und Hodgkin Lymphomen assoziiert 91. Jahrestagung der Deutschen Gesellschaft für Pathologie, Magdeburg/D, , Path Res Pract, 2007, O 50. J. Trück, G. Laube, R. von Vigier, P. Went, J.C. Streuli, Ph. Goetschel Gicht bei Kindern nach Nierentransplantation Jahreskonferenz der schweiz. Gesellschaft für Pädiatrie, Zürich/CH, , Swiss Med Wkly, 2007, P 51. R. Hiltebrand, R. Caduff, Th. Stallmach, P. Went, J. Scurry, R. Müller, V. Heinzelmann-Schwarz Differentialdiagnose einer ungewöhnlichen intrauterinen Raumforderung postpartal Jahreskongress der Schweiz. Gesellschaft für Gynäkologie und Geburtshilfe, Lugano/CH, , P 52. S. Höller, U. Mäder, A. Lohr, T. Katzenberger, J. Kalla, P. Went, H.K. Müller-Hermelink, A. Rosenwald. G. Chott High clinical impact of a combined immunohistochemical outcome predictor score (CIOPS) in diffuse large B-cell lymphoma Jahrestagung der deutschen, österreichischen und schweizerischen Gesellschaft für Onkologie, , Basel/CH, Onkologie, 30 (S3), P586, C. Meier, P. Went, A. Reiter, S. Dirnhofer, A. Tzankov Numerische und strukturelle Aberrationen des JAK2 Lokus sind häufig bei AILT-, Hodgkin-, und PMBC-Lymphomen 73. Jahrestagung der SGPath, , Basel/CH, Pathologe, U. Zingg, M. Montani, M. Busch, U. Metzger, P. Went, Ch. Örtli Prognostic influence of immunohistochemically detected lymph node metastases and histological subtype in esophageal cancer patients, 95. Jahreskongress der Schweizerischen Gesellschaft für Chirurgie, , Basel/CH, 2008, P 55. D. Franzen, P. Went, U. Buehlmann Fibrosing colonopathy - Late-onset gastrointestinal complication of cystic fibrosis?, 76. Jahresversammlung der SGIM, , Lausanne/CH, 2008, P, Swiss Med Forum, 8 (Suppl 40), U. Zingg, M. Montani, M. Busch, U. Metzger, P. Went, D. Oertli Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pn0 oesophageal cancer, 95. Jahreskongress der Schweiz. Gesellschaft für Chirurgie, , Basel/CH, 2008, P 57. A. Tzankov, P. Went, S. Dirnhofer Rational Determination of cut-off scores for prognostic biomarkers in diffuse large B-cell lymphomas, 13. Congress of the European Hematology Association, , Cannes/F, 2008, P 58. S. Dirnhofer, P. Went, A. Tzankov Cut-off value determination for prognostic markers in diffuse large B- cell lymphomas, 10th International Conference on Malignant Lymphoma, , Lugano/CH, Ann Oncol, 19 (Supp 4):071, 2008, O 59. P. P. Piccaluga, C. Agostinelli, S. Righi, A. Gazzola, M. Rossi, P. Went, P. Zinzani, S. A. Pileri Expression Of Nf-Kappa B Pathway Molecules In Peripheral T-Cell Lymphoma Not Otherwise Specified 10th

12 International Conference on Malignant Lymphoma, , Lugano/CH, Ann Oncol, 19 (Supp 4):P231, 2008, P 60. M. Busch, U. Zingg, M. Montani, U. Metzger, P. Went, D. Oertli Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pn0 oesophageal cancer, Jahresversammlung der Schweiz. Gesellschaft für Gastroenterologie, 28/ , Interlaken/CH, 2008, O 61. S. Höller, J. Kalla, U, Mäder, A. Lohr, T. Katzenberger, P. Went, H-K. Müller-Hermelink, A. Rosenwald, G. Ott High clinical impact of a combined immunohistochemical outcome predictor score (CIOPS) in diffuse large B cell lymphoma, XIV. Meeting of the European Society of Hematopathology, , Bordeaux/F, J Hematopathol 1:LS45, 2008, O 62. P.P. Piccaluga, M. Rossi, A. Esposito, P.L. Tazzari, F. Ricci, C. Agostinelli, S. Righi, A.P. Gazzola, P. Went, S. Hartmann, M. Hansmann, F. Alviano, G.B. Bagnara, P.L. Zinzani, S. Pileri Aberrant PDGFRA signalling is sustained by an autocrine loop in peripheral T-cell lymphoma not otherwise specified XIV. Meeting of the European Society of Hematopathology, , Bordeaux/F, J Hematopathol 1:LS54, 2008, O 63. M. Menigatti, E. Cattaneo, J. Sabates-Bellver, P. Went, J. Jiricny, G. Marra Inactivation of the Protein Tyrosine Phosphatase Receptor R (PTPRR) by gene promoter hypermethylation is a common and early event in colorectal carcinogenesis 9 th Charles Rodolphe Brupbacher Symposium, Zürich/CH, 2009, P